Dizal Pharmaceutical Co (SHSE:688192) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 28, 2026)


SHSE:688192 Dizal Pharmaceutical Co Ltd SHSE:688192
36 GF Score
Price ¥36.49
GF Value ¥132.14
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Dizal Pharmaceutical Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Dizal Pharmaceutical Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

SHSE:688192 vs ZTS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dizal Pharmaceutical Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dizal Pharmaceutical Co Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dizal Pharmaceutical Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Dizal Pharmaceutical Co's Margin of Safety % (DCF FCF Based) falls into.


SHSE:688192
36GF Score
Dizal Pharmaceutical Co Ltd SHSE:688192
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dizal Pharmaceutical Co (SHSE:688192) Overvalued in 2026?

Based on GuruFocus' analysis, Dizal Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥36.49 is trading 72.4% below its estimated GF Value™ of ¥132.14. GuruFocus considers Dizal Pharmaceutical Co to be Possible Value Trap.

Key valuation signals for SHSE:688192:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ¥132.14 vs. price of ¥36.49 (72.4% below fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dizal Pharmaceutical Co Business Description

Address Jinghui East Road, Room 4105, Building E (Building 5), Huirong Business Plaza, Xinwu District, Jiangsu Province, Wuxi City, CHN, 201203
Dizal Pharmaceutical Co Ltd, formerly Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
36GF Score

Get the complete analysis for SHSE:688192

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥36.49
Price
¥132.14
GF Value